To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The firm has purchased an 80% stake in clinical research specialist Medpace, whose management team will own the remaining 20 percent following the close of the transaction.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination